BS EN ISO 10993-3:2014
Superseded
View Superseded by
Biological evaluation of medical devices Tests for genotoxicity, carcinogenicity and reproductive toxicity
Hardcopy , PDF
English
10-31-2014
09-09-2026
Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 Requirements for test strategies
5 Genotoxicity tests
6 Carcinogenicity tests
7 Reproductive and developmental toxicity tests
8 Test report
Annex A (informative) - Guidance on selecting an appropriate
sample preparation procedure in genotoxicity testing
Annex B (informative) - Flowchart for follow-up evaluation
Annex C (informative) - Rationale of test systems
Annex D (informative) - Cell transformation test systems
Annex E (normative) - Considerations for carcinogenicity studies
performed as implantation studies
Annex F (informative) - In vitro tests for embryo toxicity
Bibliography
Annex ZA (informative) - Relationship between this
European Standard and the Essential
Requirements of EU Directive 93/42 EEC
on medical devices
Annex ZB (informative) - Relationship between this
European Standard and the Essential
Requirements of EU Directive 90/385/EEC on
active implantable medical devices
Describes strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices: - genotoxicity - carcinogenicity, - reproductive and developmental toxicity.
| Committee |
CH/194
|
| DevelopmentNote |
Supersedes BS EN 30993-3 and 00/561676 DC. (11/2003) Supersedes 11/30212473 DC. (10/2014)
|
| DocumentType |
Standard
|
| Pages |
48
|
| PublisherName |
British Standards Institution
|
| Status |
Superseded
|
| SupersededBy | |
| Supersedes |
This part of ISO10993 specifies strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices:
genotoxicity;
carcinogenicity;
reproductive and developmental toxicity.
This part of ISO10993 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been established.
NOTE Guidance on selection of tests is provided in ISO10993-1.
| Standards | Relationship |
| EN ISO 10993-3:2014 | Identical |
| NBN EN ISO 10993-3 : 2014 | Identical |
| ISO 10993-3:2014 | Identical |
| NS EN ISO 10993-3 : 2014 | Identical |
| I.S. EN ISO 10993-3:2014 | Identical |
| DIN EN ISO 10993-3:2015-02 | Identical |
| NF EN ISO 10993-3 : 2014 | Identical |
| NEN EN ISO 10993-3 : 2014 | Identical |
| UNE-EN ISO 10993-3:2015 | Identical |
A newer version of this standard is available.
View Current Edition